CRA was retained in an international arbitration between two Japanese affiliates of multinational pharmaceutical companies. The dispute concerned Respondent’s performance under a co-promotion agreement. CRA assessed indicators of commercially reasonable efforts using various industry data sources. CRA also quantified Claimant’s loss resulting from the alleged inadequate performance under the agreement, and responded to Respondent’s expert regarding damages alleged by Respondent.
International Arbitration Update
In this update we are sharing a short summary of CRA’s recent engagements, publications, and speaking engagements involving International Arbitration. 2021 was...